Numerous plants and phytochemicals can be used as therapeutic adjuvants in IBD and colorectal cancer associated with IBD since they can regulate Nrf2 and, therefore, among many actions, reduce inflammation and OS and increase apoptosis of cancer cells. This evidence concerns the gene NFE2L2 and inflammatory bowel disease.